Downloads provided by UsageCounts
A simple, rapid, specific, accurate and precise RP-HPLC method was developed for the simultaneous estimation of Lafutidine and Rabeprazole Sodium in combined dosage form. A Hi Q sil C-8 Column (250 mm × 4.6 mm, 5 μm) in Isocratic mode with mobile phase containing Acetonitrile : Phosphate Buffer (70:30 v/v) pH 7.3 was used. The flow rate was 1.0ml/min and effluents were monitored at 230 nm. The retention time of Rabeprazole Sodium and Lafutidine was found to be 3.658 min and 5.408 min respectively. Validation parameters such as linearity, precision, accuracy, limit of detection(LOD), limit of quantification (LOQ), robustness were determined according to the International Conference on Harmonization (ICH) Q2R1 guidelines. The detector response was linear in the range for Lafutidine 10-60 μg/ml and for Rabeprazole Sodium 20-120 μg/ml. The proposed method was successfully applied for the simultaneous estimation of LAF and RAB in pharmaceutical dosage form.
Lafutidine (LAF); Rabeprazole Sodium (RAB); RP-HPLC method
Lafutidine (LAF); Rabeprazole Sodium (RAB); RP-HPLC method
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 14 | |
| downloads | 12 |

Views provided by UsageCounts
Downloads provided by UsageCounts